泰德医药(03880)：吴东澄获委任为联席公司秘书

Core Points - Mr. Li Zhongcheng has submitted his resignation as (i) Co-Company Secretary; (ii) Authorized Representative under the Hong Kong Stock Exchange Listing Rules Section 3.05; and (iii) Representative for receiving legal documents and notifications in Hong Kong, effective from September 26, 2025 [1] - Mr. Wu Dongcheng has been appointed as Co-Company Secretary, Authorized Representative, and Legal Process Agent, effective from September 26, 2025 [1] - Ms. Li Lingmei will continue to serve as another Co-Company Secretary [1]